In addition, Globus Medical has granted the underwriters a 30-day option to purchase up to an additional 1.25 million shares of common stock to cover any over-allotments. Closing of the offering is expected to occur on Aug. 8, subject to customary closing conditions. The shares are expected to begin trading on the New York Stock Exchange today under the symbol GMED.
More Articles on Orthopedic Devices:
Global Spinal Devices and Biologics Market to Grow 6.9% Annually
DePuy Synthes Spine Systems Receive FDA Approval to Treat Scoliosis
Symmetry Medical Announces 2Q Revenue of $102.3M, 8% Increase
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
